Entity Common Stock, Shares Outstanding of Contineum Therapeutics, Inc. from 13 Aug 2024 to 27 Oct 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Contineum Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 13 Aug 2024 to 27 Oct 2025.
  • Contineum Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 27 Oct 2025 was 23,099,173.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Contineum Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 23,099,173 27 Oct 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 28,041,895 +9,047,791 +48% 31 Jul 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 25,871,549 28 Feb 2025 10-K 06 Mar 2025 2024 FY
Q2 2024 18,994,104 13 Aug 2024 10-Q 14 Aug 2024 2024 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.